Treatment of metastatic sarcomas with mitoxantrone.
D000380:Agranulocytosis / Q000139:chemically induced; D000880:Anthraquinones / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy
D000880:Anthraquinones; D000970:Antineoplastic Agents; D008942:Mitoxantrone